Taylor Wealth Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Taylor Wealth Management Partners’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.53M	Sell	24,190 -1,866	-7%	-$265K	2%	21
2022 Q1	$4.25M	Sell	26,056 -1,077	-4%	-$164K	1.72%	26
2021 Q4	$4.6M	Sell	27,133 -696	-3%	-$129K	1.62%	26
2021 Q3	$5.25M	Sell	27,829 -711	-2%	-$133K	1.87%	22
2021 Q2	$4.84M	Sell	28,540 -1,073	-4%	-$157K	1.71%	26
2021 Q1	$4.18M	Sell	29,613 -1,021	-3%	-$154K	1.53%	26
2020 Q4	$3.98M	Buy	30,634 +6	+0%	+$801	1.53%	26
2020 Q3	$4.46M	Buy	30,628 +744	+2%	+$106K	2.04%	19
2020 Q2	$4.43M	Sell	29,884 -3,836	-11%	-$517K	2.25%	16
2020 Q1	$3.67M	Buy	+33,720	New	+$3.89M	2.25%	17
2019 Q1	–	Sell	-80	Closed	-$6K	–	49
2018 Q4	$6K	Hold	80	–	–	﹤0.01%	98
2018 Q3	$7K	Hold	80	–	–	﹤0.01%	109
2018 Q2	$8K	Hold	80	–	–	﹤0.01%	115
2018 Q1	$10K	Hold	80	–	–	﹤0.01%	101
2017 Q4	$10K	Sell	80 -50	-38%	-$6.28K	﹤0.01%	127
2017 Q3	$15K	Hold	130	–	–	0.01%	121
2017 Q2	$10K	Hold	130	–	–	﹤0.01%	133
2017 Q1	$7K	Hold	130	–	–	﹤0.01%	139
2016 Q4	$5K	Hold	130	–	–	﹤0.01%	144
2016 Q3	$9K	Sell	130 -20	-13%	-$1.41K	﹤0.01%	130
2016 Q2	$8K	Sell	150 -75	-33%	-$4.72K	﹤0.01%	122
2016 Q1	$14K	Sell	225 -30,980	-99%	-$2.06M	0.01%	107
2015 Q4	$2.94M	Buy	31,205 +85	+0.3%	+$7.88K	1.27%	28
2015 Q3	$2.5M	Sell	31,120 -478	-2%	-$53.1K	1.21%	28
2015 Q2	$3.79M	Sell	31,598 -3	-0%	-$359	1.21%	34
2015 Q1	$3.3M	Buy	+31,601	New	+$3.2M	1.04%	38

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Taylor Wealth Management Partners's ALNY Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Alnylam Pharmaceuticals (ALNY) stake by 7.2% in Q2 2022, selling an estimated $265K and leaving 24,190 shares worth $3.53M. The position accounts for 2% of the portfolio, ranked #21.

Taylor Wealth Management Partners first reported a position in ALNY in Q1 2015 and has held it in 26 quarters since. The position peaked at $5.25M in Q3 2021. 423 funds tracked by Wall St. Rank hold ALNY as of Q2 2022.

Taylor Wealth Management Partners held 24,190 shares of Alnylam Pharmaceuticals worth $3.53M as of Q2 2022.
Taylor Wealth Management Partners sold 1,866 Alnylam Pharmaceuticals shares in Q2 2022, an estimated $265K.
Alnylam Pharmaceuticals made up 2% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #21 holding.
Taylor Wealth Management Partners first reported a position in Alnylam Pharmaceuticals in Q1 2015 and has held it in 26 quarters since.
Taylor Wealth Management Partners's Alnylam Pharmaceuticals position peaked at $5.25M in Q3 2021.
423 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.